CYCLOBENZAPRINE HYDROCHLORIDE Side Effects
Side effects of CYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE HYDROCHLORIDE) that impact work capacity, driving, and recovery for claims professionals, support workers, and care managers. Also known as CYCLOBENZAPRINE HYDROCHLORIDE.
CYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE HYDROCHLORIDE) is classified as Low risk by AllMeds. It is a CNS depressant that can cause drowsiness, impaired coordination, and reduced cognitive function, directly affecting work capacity and return-to-work timelines. For claims professionals, the side effects of CYCLOBENZAPRINE HYDROCHLORIDE can impact work capacity, driving fitness, and recovery timelines.
Key Takeaways
- Risk level: Low (2 points)
- CNS depressant: Causes sedation, impairs driving, affects cognitive function
- Cardiac risk: QTc prolongation, requires monitoring
- Duration limit: 14 days recommended maximum
- Claims action: Assess work capacity impact, check for dangerous interactions, review duration against guidelines
Side Effects That Affect Work Capacity
These side effects of CYCLOBENZAPRINE HYDROCHLORIDE can directly impact a claimant's ability to work, drive, and perform daily activities:
- Drowsiness and sedation
- Impaired concentration and cognitive function
- Slowed reaction time
- Impaired coordination and balance
- Nausea and constipation
Work capacity certificates should reflect any medication-related restrictions. For safety-sensitive roles (driving, operating machinery, working at heights), these effects may require modified duties or temporary stand-down.
Serious Safety Concerns
These side effects require clinical monitoring and may affect claim management decisions:
- QTc prolongation (abnormal heart rhythm)
- Risk of cardiac arrhythmia, especially with other QTc-prolonging drugs
Dependency and Withdrawal
CYCLOBENZAPRINE HYDROCHLORIDE carries a risk of physical dependence with regular use. This is a common complicating factor in injury claims:
- Physical dependence with regular use
- Tolerance requiring dose escalation
- Withdrawal symptoms on cessation
Flags for Claims Professionals
- CNS depressant effects may delay return to work, particularly in safety-sensitive roles
- QTc prolongation risk requires cardiac monitoring and drug interaction review
- Opioid dependency risk increases with duration beyond guidelines
- Recommended maximum duration: 14 days
Check this medication against your full medication list
Run a full risk assessment to check CYCLOBENZAPRINE HYDROCHLORIDE side effects, interactions, and compliance across the full medication list.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Related Resources
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.